Marker Therapeutics MRKR
NASDAQ MRKR
$1.05 -0.02 (-1.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Construction in Progress (2020 - 2022)

Updated

Marker Therapeutics (MRKR) recorded Construction in Progress of $4.09 million in Q1 2022, up 83.7% from the prior quarter.

Analysis

Marker Therapeutics (MRKR) Construction in Progress (2020 - 2022) Analysis & Trends

At the end of FY2021, Marker Therapeutics reported Construction in Progress of $2.23 million, down 67.2% from FY2020.

  • Across earlier years, Construction in Progress came in at $6.79 million in FY2020.
  • The Q1 2022 figure is the highest quarterly Construction in Progress since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Marker Therapeutics 17.87 Mn -42.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 4.09 Mn
Dec 31, 2021 2.23 Mn
Sep 30, 2021 600,005.00
Dec 31, 2020 6.79 Mn
Sep 30, 2020 4.60 Mn
Jun 30, 2020 2.63 Mn
API Access

Marker Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=MRKR&period=max&api_key=YOUR_API_KEY